253 related articles for article (PubMed ID: 28987538)
1. Development and evaluation of camptothecin loaded polymer stabilized nanoemulsion: Targeting potential in 4T1-breast tumour xenograft model.
Sugumaran A; Ponnusamy C; Kandasamy P; Krishnaswami V; Palanichamy R; Kandasamy R; Lakshmanan M; Natesan S
Eur J Pharm Sci; 2018 Apr; 116():15-25. PubMed ID: 28987538
[TBL] [Abstract][Full Text] [Related]
2. Chitosan stabilized camptothecin nanoemulsions: Development, evaluation and biodistribution in preclinical breast cancer animal mode.
Natesan S; Sugumaran A; Ponnusamy C; Thiagarajan V; Palanichamy R; Kandasamy R
Int J Biol Macromol; 2017 Nov; 104(Pt B):1846-1852. PubMed ID: 28545970
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of magnetic microemulsion: tool for targeted delivery of camptothecin to BALB/c mice-bearing breast cancer.
Natesan S; Sugumaran A; Ponnusamy C; Jeevanesan V; Girija G; Palanichamy R
J Drug Target; 2014 Dec; 22(10):913-26. PubMed ID: 25119147
[TBL] [Abstract][Full Text] [Related]
4. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
[TBL] [Abstract][Full Text] [Related]
5. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
7. Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Koo OM; Rubinstein I; Onyuksel H
Nanomedicine; 2005 Mar; 1(1):77-84. PubMed ID: 17292061
[TBL] [Abstract][Full Text] [Related]
8. Chondroitin sulfate-functionalized polymeric nanoparticles for colon cancer-targeted chemotherapy.
Zu M; Ma L; Zhang X; Xie D; Kang Y; Xiao B
Colloids Surf B Biointerfaces; 2019 May; 177():399-406. PubMed ID: 30785037
[TBL] [Abstract][Full Text] [Related]
9. Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin.
Gao Y; Li LB; Zhai G
Colloids Surf B Biointerfaces; 2008 Jul; 64(2):194-9. PubMed ID: 18325744
[TBL] [Abstract][Full Text] [Related]
10. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
11. A self-immolative prodrug nanosystem capable of releasing a drug and a NIR reporter for in vivo imaging and therapy.
Wang Z; Wu H; Liu P; Zeng F; Wu S
Biomaterials; 2017 Sep; 139():139-150. PubMed ID: 28614754
[TBL] [Abstract][Full Text] [Related]
12. Biofunctionalized polymer-lipid supported mesoporous silica nanoparticles for release of chemotherapeutics in multidrug resistant cancer cells.
Zhang X; Li F; Guo S; Chen X; Wang X; Li J; Gan Y
Biomaterials; 2014 Apr; 35(11):3650-65. PubMed ID: 24462359
[TBL] [Abstract][Full Text] [Related]
13. Glucose-conjugated glutenin nanoparticles for selective targeting and delivery of camptothecin into breast cancer cells.
Rajeshkumar RR; Pavadai P; Panneerselvam T; Deepak V; Pandian SRK; Kabilan SJ; Vellaichamy S; Jeyaraman A; Kumar ASK; Sundar K; Kunjiappan S
Naunyn Schmiedebergs Arch Pharmacol; 2023 Oct; 396(10):2571-2586. PubMed ID: 37022437
[TBL] [Abstract][Full Text] [Related]
14. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
15. Camptothecin-loaded fusogenic nanodroplets as ultrasound theranostic agent in stem cell-mediated drug-delivery system.
Ho YJ; Chiang YJ; Kang ST; Fan CH; Yeh CK
J Control Release; 2018 May; 278():100-109. PubMed ID: 29630986
[TBL] [Abstract][Full Text] [Related]
16. Dual-Responsive Polyprodrug Nanoparticles with Cascade-Enhanced Magnetic Resonance Signals for Deep-Penetration Drug Release in Tumor Therapy.
Hao Q; Wang Z; Zhao W; Wen L; Wang W; Lu S; Xing D; Zhan M; Hu X
ACS Appl Mater Interfaces; 2020 Nov; 12(44):49489-49501. PubMed ID: 33079514
[TBL] [Abstract][Full Text] [Related]
17. Targeted nanoparticles assembled via complexation of boronic-acid-containing targeting moieties to diol-containing polymers.
Han H; Davis ME
Bioconjug Chem; 2013 Apr; 24(4):669-77. PubMed ID: 23461746
[TBL] [Abstract][Full Text] [Related]
18. A novel camptothecin derivative incorporated in nano-carrier induced distinguished improvement in solubility, stability and anti-tumor activity both in vitro and in vivo.
Han M; He CX; Fang QL; Yang XC; Diao YY; Xu DH; He QJ; Hu YZ; Liang WQ; Yang B; Gao JQ
Pharm Res; 2009 Apr; 26(4):926-35. PubMed ID: 19048358
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
Wang F; Li L; Liu B; Chen Z; Li C
Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535
[TBL] [Abstract][Full Text] [Related]
20. Redox-responsive amphiphilic camptothecin prodrug nanoparticles for targeted liver tumor therapy.
Lu L; Li B; Lin C; Li K; Liu G; Xia Z; Luo Z; Cai K
J Mater Chem B; 2020 May; 8(17):3918-3928. PubMed ID: 32227058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]